A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Diseases
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Fate Therapeutics Inc.
Start Date
August 19, 2025
End Date
July 1, 2027
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Fate Therapeutics Inc.
Start Date
August 19, 2025
End Date
July 1, 2027